Comparison of an in vitro tuberculosis interferon-γ assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: A pilot study in rheumatoid arthritis

Journal of Rheumatology

Volumn 35, Issue 5, 2008, Pages 770-775

  Greenberg, Jeffrey D ^a   Reddy, Soumya M ^a   Schloss, Shari G ^a   Kurucz, Oliver S ^a   Bartlett, Susan J ^b   Abramson, Steven B ^a   Bingham III, Clifton O ^b,c  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c Center Tower ^*  (United States)

Author keywords

Rheumatoid arthritis; Skin tests diagnostic techniques; Tuberculin test; Tuberculosis

Indexed keywords

CANDIDA ANTIGEN; CANDIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; TETANUS TOXOID; TUBERCULIN;

ADULT; ARTICLE; BACTERIAL ARTHRITIS; CLINICAL TRIAL; CLONAL ANERGY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCREENING; SENSITIVITY ANALYSIS; TUBERCULIN TEST;

ADULT; ANTIGENS, BACTERIAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PILOT PROJECTS; PREVALENCE; PROSPECTIVE STUDIES; TUBERCULIN TEST; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44349111306     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montera MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 2003;48:2122-7.
2. Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004;50:372-9.
3. Askling J, Fored CM, Brandt L, et al. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 2005;52:1986-92.
4. Ehlers S. Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF Ann Rheum Dis 2003;62 Suppl 2:ii37-42.
5. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
6. Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005;52:1766-72.
7. Mariette X, Salmon D. French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers [letter]. Ann Rheum Dis 2003;62:791.
8. Ledingham J, Wilkinson C, Deighton C. British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-α treatments. Rheumatology Oxford 2005;44:1205-6.
9. Pope RM, Kniker WT, Talal N, Dauphinee M. Delayed type hypersensitivity in patients with rheumatoid arthritis. J Rheumatol 1993;20:17-20.
10. Emery P, Panayi G, Symmons D, Brown G. Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition. Ann Rheum Dis 1984;43:430-4.
11. Helliwell MG, Panayi GS, Unger A. Delayed cutaneous hypersensitivity in rheumatoid arthritis: the influence of nutrition and drug therapy. Clin Rheumatol 1984;3:39-45.
12. Paimela L, Johansson-Stephansson EA, Koskimies S, Leirisalo-Repo M. Depressed cutaneous cell-mediated immunity in early rheumatoid arthritis. Clin Exp Rheumatol 1990;8:433-7.
13. Smith MD, Smith A, O'Donnell J, Ahern MJ, Roberts-Thomson PJ. Impaired delayed type cutaneous hypersensitivity in rheumatoid arthritis reversed by chrysotherapy. Ann Rheum Dis 1989;48:108-13.
14. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001;286:1740-7.
15. Mazurek GH, Villarino ME. Guidelines for using the QuantiFeron-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003;52(RR-2):15-8.
16. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFeron-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54(RR-15):49-55.
17. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Bernstein IL, Storms WW. Practice parameters for allergy diagnostic testing. Joint Task Force on Practice Parameters for the Diagnosis and Treatment of Asthma. The American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1995;75(6 Pt 2):543-625.
19. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006;367:1328-34.
20. Geng E, Kreiswirth B, Driver C, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 2002;346:1453-8.
21. Lopez M, Jerez J, Gonzalez M, Arias M. Cell-mediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing. Allergol Immunopathol Madr 1989;17:21-8.
22. Martinez-Marcos FJ, Lopez-Cortes LF, Pachon J, Alarcon A, Cordero E, Viciana P. Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection. Clin Infect Dis 1998;26:1330-4.
23. Verwilghen J, Vertessen S, Stevens EA, Dequeker J, Ceuppens JL. Depressed T-cell reactivity to recall antigens in rheumatoid arthritis. J Clin Immunol 1990;10:90-8.
24. Ponce de Leon D, Acevedo-Vasquez E, Sanchez-Torres A, et al. Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 2005;64:1360-1.
25. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon γ assay with tuberculin skin testing for detecting latent mycobacterium tuberculosis infection. JAMA 2001;286:1740-7.
26. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 2006;7:56.
27. Moreland LW, Bucy RP, Weinblatt ME, Mohler KM, Spencer-Green GT, Chatham WW. Immune function in patients with rheumatoid arthritis treated with etanercept. Clin Immunol 2002;103:13-21.